Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
One more step toward treatment of PARP inhibitor-resistant ovarian cancers.
Oncotarget. 2023 Dec 22;14:1034-1035. doi: 10.18632/oncotarget.28545.
Oncotarget. 2023.
PMID: 38147070
Free PMC article.
No abstract available.
PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction.
Ray U, Thirusangu P, Jin L, Xiao Y, Pathoulas CL, Staub J, Erskine CL, Dredge K, Hammond E, Block MS, Kaufmann SH, Bakkum-Gamez JN, Shridhar V.
Ray U, et al.
Oncogene. 2023 Sep;42(37):2725-2736. doi: 10.1038/s41388-023-02785-5. Epub 2023 Aug 7.
Oncogene. 2023.
PMID: 37550562
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.